• The earliest cases of mesothelioma tumors were recorded in 1767, but scientists didn't understand the cause or have a name for the disease. (mesothelioma.com)
  • The first known cases of pleural tumors were in 1767. (mesothelioma.com)
  • In a study of 3,000 autopsies, Lieutaud reported two cases of pleural tumors. (mesothelioma.com)
  • Further studies on pleural tumors took place in the decades following. (mesothelioma.com)
  • In 1819, Dr. Rene Theophile Hyacinthe Laennec hypothesized pleural tumors could be malignant. (mesothelioma.com)
  • By the early 1900s, doctors generally accepted malignant tumors could originate in the pleura. (mesothelioma.com)
  • Joseph Lietaud reports the first cases of pleural tumors, which are possible cases of mesothelioma. (mesothelioma.com)
  • Pleural tumors were discovered more than two centuries ago, but researchers only made clear connections between asbestos and mesothelioma in recent decades. (mesothelioma.com)
  • Recent studies have showed that altered expression of microRNA (miRNA) is observed in human malignant tumors. (nih.gov)
  • SV40 and human tumors: myth, association or causality? (nature.com)
  • They have been imaged in vitro and also in vivo and ex vivo in tumors from human patients as well as animal models, thus not only proving their existence in the TME, but opening further speculation about their exact role in the dynamic niche of tumor ecosystems. (frontiersin.org)
  • This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. (genscript.com)
  • Given that some types of mesothelioma tumors also appear to rely on estrogen to fuel their growth , t he Irish scientists theorized that a drug like tamoxifen, which modulates estrogen receptors, could be used to enhance mesothelioma therapy. (survivingmesothelioma.com)
  • The trial included 203 malignant pleural mesothelioma patients who had one of these large bore procedures and subsequently underwent either prophylactic radiotherapy (started before new tumors appeared) or deferred radiotherapy that was based on their symptoms. (survivingmesothelioma.com)
  • An article published by French researchers late last year found that, a year after undergoing large-bore mesothelioma procedures, only 8 percent of 91 patients had experienced a recurrence of mesothelioma tumors at the intervention sites. (survivingmesothelioma.com)
  • Instead, their targeted antibodies allow them to seek out tumors and deliver the cytotoxins, which then kill malignant cells. (kazanlaw.com)
  • This is currently being evaluated in a phase I/II clinical trial in patients with malignant pleural effusion caused by advanced/metastatic solid tumors. (uvm.edu)
  • Increased understanding of the mechanism of action of STING agonists in human tumors is key to developing therapeutic combinations that activate effective innate antitumor immunity. (bvsalud.org)
  • Malignant pleural mesothelioma (MPM) is an aggressive tumor linked to environmental/occupational exposure to asbestos, characterized by the presence of significant areas of hypoxia. (units.it)
  • Malignant pleural mesothelioma (MPM) is an aggressive tumor with a dismal prognosis. (nih.gov)
  • A team of medical researchers in Italy have achieved what they are calling "excellent" tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. (survivingmesothelioma.com)
  • After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. (survivingmesothelioma.com)
  • The authors describe a single case with an uncharacteristic pattern of disease and their two conclusions that the long survival observed could be either attributed to 'margin-free tumor resection' or to the fact that some subgroups have `lower malignant potential, leading to improved survival' are entirely reasonable. (biomedcentral.com)
  • One unusual feature of mesothelioma is that patients frequently present with tumor-associated pleural effusions early in the course of the disease. (iospress.com)
  • In mesothelioma, over 80% of cases are associated with a pleural effusion that bathes the tumor [ 10 ]. (iospress.com)
  • In collaboration with Cunniff's lab, the team then evaluated molecular signatures of human biphasic mesothelioma tumor cells following treatment with the irreversible PRX3 inhibitor RSO-021. (uvm.edu)
  • Moreover, the fibrous nature of the tumor has given rise to various other names, such as pleural fibroma, submesothelial fibroma, and localized fibrous tumor. (medscape.com)
  • A number of PSPs have been defined over the years that include, but not limited to, promoters of prostate-specific antigen (PSA), probasin (PB), mouse mammary tumor virus (MMTV LTR), prostate-specific membrane antigen (PSMA), human glandular kallikrein 2 (hK2), and prostatic steroid-binding protein C3. (hindawi.com)
  • Tumor and background lung tissue microarrays prepared from archival surgical specimens of 139 pleural mesothelioma cases, collected over a period of 8 years (1998 to 2005), were analyzed. (mesothelioma-line.com)
  • These studies reveal the fundamental importance of using human tumor samples to assess innate and cellular immune therapies. (bvsalud.org)
  • By functionally profiling mesothelioma tumor explants with elevated STING expression in tumor cells, we uncovered distinct consequences of STING agonist treatment in humans that support testing combining STING agonists with NK and CAR-NK cell therapies. (bvsalud.org)
  • Tumor volume (TV) has improved performance compared with clinical staging, whereas neutrophil-to-lymphocyte ratio (NLR) is prognostic for malignant pleural mesothelioma. (bvsalud.org)
  • a malignant tumor of the pleura and/or peritoneum, is characterized by a long latency from exposure to disease onset, with a median of approximately 40 years. (msdmanuals.com)
  • Malignant mesothelioma is an uncommon cancerous tumor . (medlineplus.gov)
  • Title: Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma. (genscript.com)
  • Methods Fibulin-3 and soluble mesothelin were determined by ELISA in the plasma and pleural fluid of 153 patients presenting with a pleural effusion including 82 with MM, 36 with non-MM malignant effusions and 35 with benign effusions. (bmj.com)
  • While fibulin-3 levels are elevated in the plasma of mesothelioma patients compared with controls, soluble mesothelin has a much greater diagnostic accuracy and fibulin-3 levels in pleural effusions are not specific for mesothelioma. (bmj.com)
  • To study whether cells and molecules present in pleural effusions provide prognostic information for mesothelioma. (iospress.com)
  • This study demonstrates that pleural effusions rich in a range of soluble factors are associated with poor prognosis. (iospress.com)
  • Savic et al used fluorescence in situ hybridization (FISH) to distinguish malignant mesothelioma from reactive mesothelial cells in effusions. (medscape.com)
  • Diffuse pleural thickening can occur after nonmalignant pleural effusions and can be associated with restrictive deficits, dyspnea, and chest pain. (msdmanuals.com)
  • Pleural Effusion Pleural effusions are accumulations of fluid within the pleural space. (msdmanuals.com)
  • Conclusions: Malignant effusions constituted 17 percent of all the effusions examined. (bvsalud.org)
  • Adenocarcinomas were the most frequently diagnosed metastatic malignancies in both pleural and ascitic effusions and in both females and males. (bvsalud.org)
  • Nonmesotheliomatous cancers of the pleura include an assortment of malignant neoplasms that primarily or secondarily involve pleura. (medscape.com)
  • The current research has two axes: one on malignant pleural mesothelioma (the MESOMICS and MESOMICS2 projects), and one on neuroendocrine neoplasms (the lungNENomics and panNENomics projects). (who.int)
  • Dr. Irving J. Selikoff announces findings that members of New York-area asbestos workers unions have a higher-than-expected mortality rate from lung and pleural cancers. (mesothelioma.com)
  • In 1943, researcher H.W. Wedler reported a connection between asbestosis and pleural cancers. (mesothelioma.com)
  • Peritoneal cancers, such as primary ovarian cancer and peritoneal mesotheliomas, are characterized by a hallmark of localized or regional dissemination within the peritoneal cavity. (frontiersin.org)
  • His book "Surviving Mesothelioma and Other Cancers: A Patient's Guide" details his cancer voyage, the decisions he made, and his philosophies about health and healing. (survivingmesothelioma.com)
  • She has expertise in treating thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, malignant pleural mesothelioma and thymic cancers. (umaryland.edu)
  • We know only too well that all cancers, including mesothelioma are variable in their clinical behaviour and although histopathological examination (and now genomic testing) can provide clinically useful sub-classification, it is never a reliable predictor of outcome. (biomedcentral.com)
  • Whereas pleural mesothelioma is highly associated with asbestos exposure , nonmesotheliomatous cancers have generally not been proven to result from exposure to airborne asbestos. (medscape.com)
  • The VOYAGER project brings together a consortium of five cohort studies, including three studies in North America and two studies in the United Kingdom and Europe, to learn more about how inherited genetic factors affect risk and outcomes of oral cavity cancer and human papillomavirus (HPV) infection-related oropharyngeal cancers. (who.int)
  • fibulin-3 confers a relatively high diagnostic efficacy and is acceptable to be an auxiliary biomarker to aid in malignant pleural mesothelioma identification. (genscript.com)
  • Krebs von den Lungen-6 (KL-6) is a human mucin 1 (MUC1) glycoprotein, which has shown diagnostic and prognostic value as a biomarker in other malignancies. (lu.se)
  • The present study investigated whether KL-6 can serve as a diagnostic and/or prognostic biomarker in PM. Materials and methods: Using a fully-automated chemiluminescence enzyme immunoassay (CLEIA) for KL-6 and SMRP, pleural effusion samples from 87 consecutive patients with PM and 25 patients. (lu.se)
  • How does the diagnostic accuracy of the newly proposed malignant mesothelioma biomarker fibulin-3 compare with the 'gold standard' biomarker, soluble mesothelin? (bmj.com)
  • Hollevoet et al found that megakaryocyte potentiating factor (MPF) can be used as a serum biomarker of malignant mesothelioma. (medscape.com)
  • MPF originates from the same precursor protein as soluble mesothelin (SM), which is currently the reference serum biomarker for malignant mesothelioma. (medscape.com)
  • Chronic exposure to carbon nanotube s induces invasion of human mesothelial cells through matrix metalloproteinase-2. (cdc.gov)
  • Here, we investigate the effect of long-term exposure to high aspect ratio CNTs on the aggressive behaviors of human pleural mesothelial cells, the primary cellular target of human lung mesothelioma. (cdc.gov)
  • Since then, the SV40 oncogenic protein large T antigen (SV40 Tag) has been shown to cause malignant transformation of asbestos-treated human pleural mesothelial cells and malignant pleural mesotheliomas in asbestos-exposed SV40 Tag transgenic mice. (mesothelioma-line.com)
  • Malignancies involving mesothelial cells that normally line the body cavities, including the pleura (see the images below), peritoneum, pericardium, and testis, are known as malignant mesothelioma. (medscape.com)
  • Hier de conclusie van deze review en daaronder een studie abstract met ranpirnasse uit 2002 met bijzonder goede resultaten op de mediane overlevingstijd. (kanker-actueel.nl)
  • It was under development for the treatment of relapsed or refractory multiple myeloma, glioblastoma multiforme, blood cancer, metastatic non-small cell lung cancer and malignant pleural mesothelioma. (pharmaceutical-technology.com)
  • However, malignant SFTs, which comprise 10%-15% of SFTs, not only aggressively infiltrate adjacent structures but are also capable of metastatic spread. (medscape.com)
  • Pathology reports from 1997 to 2006 were reviewed at two academic institutions to identify patients with proven pleural mesothelioma. (nih.gov)
  • Twenty-eight consecutive patients referred for the evaluation of suspected malignant mesothelioma were evaluated by FDG-PET imaging. (nih.gov)
  • Surgical biopsy specimens confirmed the presence of malignant disease in 24 patients and demonstrated benign processes in the remaining four. (nih.gov)
  • Histologic examination in six patients confirmed malignant nodal disease in five cases and indicated granulomatous lymphadenitis in one. (nih.gov)
  • Today, doctors and researchers are working to improve diagnosis and treatment for mesothelioma patients. (mesothelioma.com)
  • SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma. (antibodies-online.com)
  • The four cell lines were treated with a combination of tamoxifen and the platinum-based drug cisplatin , one of the primary components of chemotherapy for mesothelioma patients. (survivingmesothelioma.com)
  • The news was encouraging for mesothelioma patients. (survivingmesothelioma.com)
  • The ER-independent actions of tamoxifen on malignant pleural mesothelioma cell proliferation and cell cycle progression may have clinical benefits for a subset of patients with MPM," concludes Dr. Jennings. (survivingmesothelioma.com)
  • It has not yet been studied in the treatment of mesothelioma patients. (survivingmesothelioma.com)
  • In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. (survivingmesothelioma.com)
  • Should mesothelioma patients consider having radiotherapy as a way to keep their symptoms from coming back after surgery? (survivingmesothelioma.com)
  • In an article published in the online medical journal PLoS One , researchers concluded that radiotherapy aimed at stopping the spread of pleural mesothelioma and delaying the return of symptoms may not not have much of an impact on quality of life for patients. (survivingmesothelioma.com)
  • Mesothelioma patients in the SMART trial were asked to fill out quality of life questionnaires to determine how big an impact radiotherapy had. (survivingmesothelioma.com)
  • PM patients with high pleural effusion KL-6 levels (≥303 IU/mL) had significantly better overall survival (OS) compared to those with low KL-6 levels (HR 0.51, p = 0.004). (lu.se)
  • No association between simian virus 40 and diffuse malignant mesothelioma of the pleura in Iranian patients: a molecular and epidemiologic case-control study of 60 patients. (cdc.gov)
  • Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection. (umaryland.edu)
  • For virtually all patients with mesothelioma the term 'macroscopic complete resection' is misleading. (biomedcentral.com)
  • So this case report does not really help us manage better the great majority of patients with mesothelioma. (biomedcentral.com)
  • Less than 10% of mesothelioma patients survive 5 years post diagnosis. (iospress.com)
  • We profiled the cellular constituents and concentrations of 40 cytokines, chemokines and cellular factors (collectively "soluble factors") involved in inflammatory and immune signalling pathways in pleural effusion samples from 50 mesothelioma patients. (iospress.com)
  • Survival analysis revealed that IL8, IL2Ra (CD25) and PF4 were independent determinants of a more negative prognosis in mesothelioma patients, independent of other known prognostic factors. (iospress.com)
  • These findings will enhance our ability to prognosticate outcomes in mesothelioma patients. (iospress.com)
  • The article cited below by Professor of Lung Cancer & Mesothelioma Daniel Murphy from Glasgow University included information about the occurrence and causation of mesothelioma and an update on progress by UK researchers into learning about the disease and how to treat mesothelioma patients. (ibasecretariat.org)
  • The aim of this research was to explore the lived experience of patients diagnosed with Malignant Pleural Mesothelioma in the United States and identify unmet patient needs. (belluckfox.com)
  • Should mesothelioma patients get the COVID-19 vaccine booster? (belluckfox.com)
  • The combination of galinpepimut-S and nivolumab (Opdivo) was found to extend survival in patients with malignant pleural mesothelioma who were either refractory to, or who had relapsed after, at least 1 line of standard therapy, according to updated data from a phase 1 trial (NCT04040231). (asbestos-mesothelioma.com)
  • These] updated data [are] very encouraging, as it not only confirms our data reported in June 2021, but now reflects an increased survival benefit even though almost all additionally enrolled patients had grade III and IV malignant mesothelioma," Angelos Stergiou, MD, ScDhc, president and chief executive officer of SELLAS Life Sciences Group, Inc., stated in a press release. (asbestos-mesothelioma.com)
  • More than 90% of patients with pleural mesothelioma present with pleural effusion that decreases after thoracentesis. (medscape.com)
  • The circulating SMRP level has been reported to be elevated in 84% of patients with malignant mesothelioma and in 2% of patients with lung cancer. (medscape.com)
  • Pleural fluid findings in patients with mesothelioma are normally not diagnostic. (medscape.com)
  • Dyspnea and nonpleuritic chest wall pain are the most common presenting symptoms of malignant pleural mesothelioma, with at least 1 of these occurring in 60-90% of patients. (medscape.com)
  • Patients may also be asymptomatic, with evidence of a pleural effusion noted incidentally on physical examination or by chest radiograph. (medscape.com)
  • Among patients with malignant pleural mesothelioma, 77% have previously been exposed to asbestos. (medscape.com)
  • With improved understanding of the pathogenesis of mesothelioma, new diagnostic, preventive and therapeutic options are being developed. (nature.com)
  • Title: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis. (genscript.com)
  • GATA binding protein 3 (GATA3) has been suggested as a diagnostic marker for sarcomatoid mesothelioma. (edu.au)
  • In addition, the discovery of elevated levels of various markers such as folic acid receptor alpha, cyclooxygenase 2, and multidrug resistance proteins 1 and 2 in mesothelioma tissue have opened up new areas of potential diagnostic and therapeutic importance. (mcmaster.ca)
  • Results Mesothelin provides better diagnostic accuracy than fibulin-3 for MM whether measured in plasma or pleural effusion: area under the curve (AUC) for plasma was 0.822 (95% CI 0.76 to 0.87) compared with 0.671 (0.61 to 0.73), respectively, and for pleural fluid AUC was 0.815 (0.74 to 0.87) compared with 0.588 (0.51 to 0.67), respectively. (bmj.com)
  • Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis over welke aanpak bij mesothelioma eventueel zou kunnen werken. (kanker-actueel.nl)
  • Careful scrutiny of routinely stained biopsy preparations is the most valuable diagnostic tool in malignant mesothelioma. (medscape.com)
  • Diagnostic features distinguishing malignant mesothelioma from adenocarcinoma include negative test results for periodic acid-Schiff stain, mucicarmine stain, carcinoembryonic antigen, and Leu M1 and positive test results for calretinin, vimentin, and cytokeratin. (medscape.com)
  • most often, however, the pleural fluid cytology results are not diagnostic. (medscape.com)
  • Routinely stained biopsy preparations are the most valuable diagnostic tool in malignant mesothelioma. (medscape.com)
  • To review the computed tomography (CT) imaging findings of pleural mesothelioma at presentation and to correlate the CT with the histological subtype. (nih.gov)
  • Computed tomography scan of a 58-year-old patient with mesothelioma and shortness of breath. (medscape.com)
  • CT often cannot differentiate between benign diffuse pleural thickening and malignant mesothelioma, while thoracentesis and CT-guided biopsies are insensitive. (nih.gov)
  • With a SUV cutoff of 2.0 to differentiate between malignant and benign disease, a sensitivity of 91% and a specificity of 100% could be achieved, although the activity in some epithelial mesotheliomas tended to be close to this threshold. (nih.gov)
  • Furthermore, they can connect malignant cells to benign cells, including vascular endothelial cells. (frontiersin.org)
  • it is not easy to differentiate between benign and malignant lesions. (bvsalud.org)
  • The remaining imaging findings are not helpful in predicting the histological subtype of malignant mesothelioma. (nih.gov)
  • We investigated the immunohistochemical labeling and associations for GATA3, BRCA1-associated protein 1 (BAP1), and Ki67 labeling in three major histological types of pleural malignant mesotheliomas. (edu.au)
  • Using biphasic mesotheliomas as a model containing both epithelioid and sarcomatoid features, investigators at the University of Leicester conducted a geospatial analysis of patient tissues to explore the molecular signatures associated with the histological regions. (uvm.edu)
  • In this paper, the authors provided details of 33 cases of diffuse pleural mesothelioma that occurred in residents of South Africa's Cape Province. (mesothelioma.com)
  • Asbestos-related pleural thickening is characterized by diffuse, extensive thickening of the visceral pleura with areas of adherence to the parietal pleura and obliteration of the pleural space. (msdmanuals.com)
  • Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer associated with median survival of 7-13 months from diagnosis and limited effective treatment options (Beebe-Dimmer et al. (atlasgeneticsoncology.org)
  • He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. (survivingmesothelioma.com)
  • Although the SMART trial data suggests that prophylactic radiotherapy may not have much impact on quality of life for people diagnosed with mesothelioma , there is still evidence that it may help keep mesothelioma from spreading and extend survival. (survivingmesothelioma.com)
  • The mesothelioma prognostic test (MPT) and molecular subtype based on claudin-15-to-vimentin expression ratio are molecular signatures associated with survival. (bvsalud.org)
  • 2005). SV40 enhances the risk of malignant mesohelioma among people exposed to asbestos: a molecular epidemiological case-control study. (nature.com)
  • Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. (nih.gov)
  • During the past few years, there has been significant progress in understanding the process of mineral fiber carcinogenesis and mesothelioma pathogenesis. (nature.com)
  • Hmeljak J, Kern I, Cör A. No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia. (cdc.gov)
  • Asbestos, particularly the types of amphibole asbestos known as crocidolite and amosite asbestos, is the principal carcinogen implicated in the pathogenesis of malignant pleural mesothelioma. (medscape.com)
  • McCusker MG, Scilla KA , Simone CB 2nd, Sachdeva A, Miller KD, Burke AP, Rolfo C. Proton Beam Therapy and Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma. (umaryland.edu)
  • Malignant pleural mesothelioma is associated with asbestos exposure and poor outcomes. (edu.au)
  • In malignant pleural mesothelioma (MPM), a lethal disease associated with asbestos exposure, men outnumber women 4 to 1, but women consistently live longer than men following surgery-based therapy. (bvsalud.org)
  • Seventy-two of the 92 mesotheliomas were epithelial, 15 sarcomatous, and 5 of mixed histology. (nih.gov)
  • By definition, pseudomesotheliomatous carcinoma refers to an epithelial neoplasm that secondarily involves the pleura and encases the lung, thereby simulating the radiologic and macroscopic appearance of malignant mesothelioma. (medscape.com)
  • Results: Studies to date have shown that human T-cells engineered to express cMet CARs can destroy mesothelioma tumour cell monolayers, accompanied by T-cell proliferation and cytokine production. (aacrjournals.org)
  • The result is a comprehensive review of the research field of asbestos carcinogenesis and mesothelioma, and of the progress that has been made in recent years in both basic and clinical sciences. (nature.com)
  • The potential usefulness of GATA3 for prognostication and its clinical and pathological correlations in different subtypes of mesothelioma have not been evaluated. (edu.au)
  • We examined 149 clinically annotated malignant mesotheliomas and assessed associations of GATA3 expression with clinical variables and prognosis. (edu.au)
  • 5 (5/19) lesions were associated with human papillomavirus (HPV) infection. (bvsalud.org)
  • Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P and Lauro R (2001) Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. (scielo.br)
  • Examples of large bore procedures include thoracic surgery, a large bore chest drain, indwelling pleural catheters, or thoracoscopy. (survivingmesothelioma.com)
  • In 2011, researchers from Bayer Pharmaceuticals registered BAY 94-9343, an ADC that targets mesothelin, a protein that is overproduced in all forms of mesothelioma. (kazanlaw.com)
  • Using a cytotoxin called DM4, this drug binds to and kills only cells that produce mesothelin - and the more mesothelin a malignant cell creates, the more likely it is to absorb BAY 94-9343 and die. (kazanlaw.com)
  • In addition, other possible factors such as the presence of simian virus 40 and genetic susceptibility have been associated recently with the development of mesothelioma in animal models. (mcmaster.ca)
  • The role of CYP1A1 , GSTM1 , GSTT1 , EPHX1 , and NAT2 genotypes in susceptibility to malignant mesothelioma (MM) was compared in two case-control studies, previously conducted in two countries where different types of asbestos fibers have been used [Hirvonen et al. (mesothelioma-line.com)
  • 2005. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. (mesothelioma-line.com)
  • Dr. Perez-Soler has published over a hundred articles, and papers including, "Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib," published in the Cancer Chemother Pharmacol in January of 2009. (mesothelioma.com)
  • Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling. (antibodies-online.com)
  • We envisage that regional i.e. intrapleural delivery of human CAR positive T-cells could be used to maximise therapeutic index of this approach. (aacrjournals.org)
  • The researchers tested tamoxifen in four different mesothelioma cells lines in the laboratory. (survivingmesothelioma.com)
  • Tamoxifen inhibited the growth of malignant pleural mesothelioma cells and also modulated their sensitivity to cisplatin," writes study author Cormac Jennings, PhD, a molecular medicine specialist with Beaumont Hospital in Dublin. (survivingmesothelioma.com)
  • The result was an interruption of the normal cell cycle for these mesothelioma cells and an increase in apoptosis , the natural process of programmed cell death. (survivingmesothelioma.com)
  • Because radiotherapy disturbs the DNA of cells along the insertion path, some studies have suggested that it may help keep pleural mesothelioma from gaining a foothold there. (survivingmesothelioma.com)
  • MV-NIS attacks cells expressing the human CD46 antigen and it also acts as an activator of human thyroidal sodium iodide symporter. (pharmaceutical-technology.com)
  • Here, we report that malignant pleural mesothelioma cells robustly express STING and are responsive to STING agonist treatment ex vivo. (bvsalud.org)
  • Gross pathology reveals that the pleural surfaces are seeded with malignant mesothelioma cells, which form grouped nodules. (medscape.com)
  • The Mutographs research project aims to advance the understanding of the causes of cancer through studies of mutational signatures by (i) elucidating the causes of major global geographical and temporal differences in cancer incidence through the study of mutational signatures, (ii) identifying and characterizing the biological processes underlying mutational signatures, and (iii) surveying and monitoring mutagenic exposures in normal cells in humans through mutational signature analysis. (who.int)
  • Because of research done with SV40 in animal models, there has been some concern that the virus could cause cancer in humans. (cdc.gov)
  • Lundstig A, Dejmek A, Eklund C, Filinic I, Dillner J. No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden. (cdc.gov)
  • Is there a role for SV40 in human cancer? (cdc.gov)
  • Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? (mesothelioma-line.com)
  • The present study was designed to investigate the possible association of SV40 Tag with human malignant pleural mesothelioma samples from birth cohorts of the UK population exposed to combined peak levels of asbestos and SV40-contaminated polio vaccines. (mesothelioma-line.com)
  • The complete absence of SV40 Tag mRNA in this large series of cases contradicts experimental evidence suggestive of SV40 link with asbestos-exposed malignant pleural mesotheliomas in the UK population. (mesothelioma-line.com)
  • Typically, the pleural fluid has less than 1000 leukocytes per microliter, few erythrocytes, elevated protein levels, and normal lactate dehydrogenase levels. (medscape.com)
  • As the disease progresses, it covers the entire pleural space and invades the chest wall, mediastinum, and diaphragm. (medscape.com)
  • GATA3 was positive in 75 of 149 (50%) mesotheliomas, with the highest incidence of labeling seen in the sarcomatoid subtype (73%), compared with the biphasic (50%) and epithelioid (40%), mesotheliomas. (edu.au)
  • INTRODUCTION: Prognostic models for malignant pleural mesothelioma have been limited to demographics, symptoms, and laboratory values. (bvsalud.org)
  • Call for an appointment with your provider if you have symptoms of malignant mesothelioma. (medlineplus.gov)
  • 1995. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. (mesothelioma-line.com)
  • Asbestos-related pleural plaques are the most common manifestation of asbestos exposure. (msdmanuals.com)
  • Often pleural plaques are asymptomatic, although because they result from asbestos exposure, they increase the risk of other asbestos-related lung disease. (msdmanuals.com)
  • The specific gravity of the pleural fluid is also nondiagnostic. (medscape.com)
  • The term fibroma is inappropriate because the neoplasm exhibits defined histologic features that differ from those of fibromas and may express malignant behavior. (medscape.com)
  • First, a human antibody (or immune protein) that identifies a specific form of cancer. (kazanlaw.com)
  • it is comprised of 4 peptide chains, 2 of which are modified chains that induce a strong, innate immune response against WT1 antigen and access a wide range of human leukocyte antigen types. (asbestos-mesothelioma.com)
  • All of the lines possess surface human leukocyte antigen (HLA) class I and intercellular adhesion molecule-1 (ICAM-1). (medscape.com)
  • A case report of an unusual case of mesothelioma prompts a discussion and concludes that they do have a role but that their observations and conclusions need to be treated with care. (biomedcentral.com)
  • A total of eight desmoplastic mesotheliomas showed labeling with GATA3. (edu.au)
  • GATA3 is a useful marker for sarcomatoid mesothelioma, including the desmoplastic subtype. (edu.au)